# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Bayer's Phase 3 study OASIS 3 findings on elinzanetant, a promising non-hormonal treatment for menopausal hot flashes. Resu...
HC Wainwright & Co. analyst Vernon Bernardino downgrades Acer Therapeutics (NASDAQ:ACER) from Buy to Neutral.
Gainers Edible Garden AG Incorporated (NASDAQ: EDBL) surged 181.1% to $3.63. TradeUP Acquisition Corp. (NASDAQ: UPTD) gaine...
Roth Capital analyst Jonathan Aschoff downgrades Acer Therapeutics (NASDAQ:ACER) from Buy to Neutral and maintains $1.5 pric...